Yüklüyor......
Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET
Hypoxia is associated with resistance to radiotherapy and chemotherapy. Functional imaging of hypoxia in non-small cell lung cancer (NSCLC) could allow early assessment of tumor response and guide subsequent therapies. Epidermal growth factor receptor (EGFR) inhibition with erlotinib reduces hypoxia...
Kaydedildi:
| Yayımlandı: | Technol Cancer Res Treat |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565779/ https://ncbi.nlm.nih.gov/pubmed/25759424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1533034615574386 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|